Investor Relations


Corporate Profile

CVRx® is a leader in the development of safe and effective therapies to address unmet needs in cardiovascular disease. Headquartered near Minneapolis, Minn., CVRx is dedicated to improving patient outcomes, quality of life and overall cardiovascular health via our novel baroreceptor neuromodulation therapies.
(Common Stock)
12:14 AM EDT / 07.13.2024

Data Provided by Refinitiv.

Minimum 15 minutes delayed.